Familial hypercholesterolaemia: open trials in Australia

• NCT07894887

  EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)

  Trial Treatment · Phase 1/2 · Editas Medicine, Inc.

  Clinical Study Center, Charlestown · Clinical Study Center, Perth

  Registry updated 2026-10-26

• NCT06451770

  Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

  Trial Treatment · Phase 1 · Verve Therapeutics, Inc.

  Clinical Study Center, Adelaide · Clinical Study Center, Melbourne

  Registry updated 2026-10-23

• NCT05325034

  Guideline Oriented Approach To Lipid Lowering In Asia-Pacific

  Trial Treatment · Stephen Nicholls

  Flinders Medical Centre, Bedford Park · Cairns & Hinterland Hospital & Health Service, Cairns · Monash Health, Clayton · Western Health, Melbourne · Illawarra Shoalhaven Local Health District, Wollongong

  Registry updated 2026-10-08

• NCT07058077

  A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

  Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC

  Monash Children s Hospital (Site 1603), Clayton · Perth Children s Hospital (Site 1601), Nedlands

  Registry updated 2026-10-07

• NCT07428473

  A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

  Trial Treatment · Phase 1 · Monash University

  Monash Health/ Victorian Heart Hospital (VHH), Clayton

  Registry updated 2026-09-21

• NCT07491172

  A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

  Trial Treatment · Phase 1 · CRISPR Therapeutics AG

  Royal Adelaide, Adelaide · CORE Research, Brisbane · Royal Prince Alfred Hospital, Camperdown · Austin Health, Heidelberg · Monash Medical Center, Melbourne

  Registry updated 2026-09-18

• NCT06164730

  A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

  Trial Treatment · Phase 1 · Verve Therapeutics, Inc.

  Clinical Study Center, Adelaide · Clinical Study Center, Melbourne · Clinical Study Center, Sydney

  Registry updated 2026-09-02

All Familial hypercholesterolaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error